NFE2L2 and ovarian carcinoma: However, contradictory evidence exists; for instance, other studies have suggested that NFE2L2 induces cisplatin resistance by suppressing the iron export gene SLC40A1 in ovarian cancer cells[84], indicating the presence of unknown feedback mechanisms.